Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “H7N9 Influenza Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT07496450
What this trial is testing

MRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults

Who this might be right for
Influenza
ModernaTX, Inc. 4,050
Testing effectiveness (Phase 2)Study completedNCT01323946
What this trial is testing

Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children

Who this might be right for
Influenza
GlaxoSmithKline 113
Testing effectiveness (Phase 2)Looking for participantsNCT06842173
What this trial is testing

Safety and Immunogenicity of the Monovalent Influenza Vaccine A (H5N8) (Inactivated, Fragmented and Adjuvanted) in Adults and Older Adults

Who this might be right for
Avian Influenza A Virus
Butantan Institute 700
Early research (Phase 1)Study completedNCT02151344
What this trial is testing

Evaluating the Safety and Immune Response to a Live H7N9 Influenza Virus Vaccine Followed by an Inactivated H7N9 Influenza Virus Vaccine, Given at Varying Intervals

Who this might be right for
Influenza A Virus, H7N9 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 100
Not applicableStudy completedNCT00428493
What this trial is testing

Prospective Study of AI H5N1 in China

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 4,000
Testing effectiveness (Phase 2)Study completedNCT03283319
What this trial is testing

Panblok H7 Vaccine Adjuvanted With AS03 or MF59

Who this might be right for
Influenza, Human
Biomedical Advanced Research and Development Authority 366
Testing effectiveness (Phase 2)Study completedNCT01578317
What this trial is testing

Immune Responses to H5N1 Vaccine With and Without AS03 Adjuvant

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 43
Early research (Phase 1)Study completedNCT00310206
What this trial is testing

H5N1 Vaccine Intramuscular Versus Intradermal in Healthy Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 100
Early research (Phase 1)Study completedNCT03651544
What this trial is testing

The Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac

Who this might be right for
Influenza A Virus InfectionInfluenza AInfluenza Epidemic+1 more
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 36
Large-scale testing (Phase 3)Study completedNCT02107807
What this trial is testing

Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine

Who this might be right for
Influenza, HumanFlu, HumanFlu, Avian+2 more
Seqirus 539
Testing effectiveness (Phase 2)Study completedNCT03755427
What this trial is testing

An Adjuvanted Inactivated H7N9 Influenza Vaccine

Who this might be right for
H7N9 Influenza
Shanghai Institute Of Biological Products 560
Testing effectiveness (Phase 2)Study completedNCT06382311
What this trial is testing

Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults

Who this might be right for
Influenza, Human
GlaxoSmithKline 991
Not applicableStudy completedNCT01150552
What this trial is testing

Studies of Avian Influenza Transmission to Humans in Egypt

Who this might be right for
Avian Influenza
St. Jude Children's Research Hospital 1,000
Testing effectiveness (Phase 2)Study completedNCT00240968
What this trial is testing

H5 Booster After a Two Dose Schedule

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 337
Testing effectiveness (Phase 2)Study completedNCT00311480
What this trial is testing

Safety and Immunogenicity of Two Doses, Administered Three Weeks Apart, of Two(Surface Antigen Adjuvanted With MF59C.1) Influenza Vaccines in Non-Elderly Adult and Elderly Subjects

Who this might be right for
Pandemic Influenza Disease
Novartis 520
Testing effectiveness (Phase 2)Study completedNCT00530660
What this trial is testing

Safety and Immunogenicity Study of a Booster Vaccination With a Non-Adjuvanted H5N1 Influenza Vaccine (Follow Up to Study 810501)

Who this might be right for
Influenza
Alachua Government Services, Inc. 141
Early research (Phase 1)Study completedNCT00532792
What this trial is testing

A/H5N1 Dose Ranging Study With Adjuvant Patch

Who this might be right for
Pandemic Influenza
Intercell USA, Inc. 501
Early research (Phase 1)Study completedNCT00439530
What this trial is testing

Pharmacologic Study of Oseltamivir in Healthy Volunteers

Who this might be right for
Avian Influenza A Virus
Mahidol University 21
Early research (Phase 1)Study completedNCT01594320
What this trial is testing

A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 1

Who this might be right for
Influenza (Pandemic)
Novavax 333
Early research (Phase 1)Study completedNCT02295813
What this trial is testing

Safety and Pharmacokinetics Study of FBF001

Who this might be right for
Avian Influenza
Fab'entech 16
Next Page